7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expression of enzymatic activity by unknown
7B2 Facilitates the Maturation of proPC2 in Neuroendocrine Cells 
and Is Required for the Expression of Enzymatic Activity 
Xiaorong Zhu and Iris Lindberg 
Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, New Orleans, Louisiana 70112 
Abstract. The prohormone convertase PC2, which is 
thought to mediate the proteolytic conversion of many 
peptide hormones, has recently been shown to interact 
with the neuroendocrine-specific polypeptide 7B2 in 
Xenopus intermediate lobe (Braks, J. A. M., and G. J. M. 
Martens. Cell 78:263. 1994). In the present work we 
have stably transfected neuroendocrine cell lines with 
rat 7B2 constructs and found that overexpression of 27 
kD 7B2 greatly facilitates the kinetics of maturation of 
proPC2, both in AtT-20/PC2 cells and in Rin5f cells. 
The half-life of conversion of proPC2 was reduced from 
2.7 to 1.7 h in AtT-20/PC2 cells stably transfected with 
27 kD 7B2 cDNA. The previously proposed "chaper- 
one" domain was not sufficient for this facilitation 
event; however, a construct corresponding to the 21-kD 
7B2 protein (which represents the naturally occur- 
ring maturation product) functioned well. A 7B2 
construct in which maturation of 27 kD 7B2 to its 
21-kD form was blocked was unable to facilitate mat- 
uration of proPC2. 
To correlate effects on PC2 maturation with the 
actual generation of PC2 enzymatic activity, a similar 
transfection of 21 kD 7B2 was performed using CHO 
cells previously amplified for the expression of proPC2. 
Enzymatic activity cleaving the fluorogenic substrate 
Cbz-Arg-Ser-Lys-Arg-AMC was highly correlated with 
the expression of immunoreactive 21 kD 7B2 in the 
conditioned medium; medium obtained from the 
parent cell line was completely inactive. Enzymatic 
activity was identified as PC2 on the basis of inhibition 
by the carboxy-terminal peptide of 7B2, which has 
previously been shown to represent a potent and 
specific PC2 inhibitor. Taken together, our in vivo 
results indicate that the interesting secretory protein 
7B2 is a bifunctional molecule with an amino-terminal 
domain involved in proPC2 transport as well as 
activation. 
B 
IOLOGICALLY  active peptide hormones secreted from 
neuroendocrine cells are derived through the pro- 
cessing of prohormones through a series of post- 
translational modifications.  This process  begins  with co- 
translational  secretion  of precursor  molecules  into  the 
lumen of the endoplasmic reticulum. The precursor under- 
goes  proteolytic cleavage,  oligosaccharide  addition  and 
other required refinements during transport through the 
secretory pathway before release as bioactive peptide. For 
most polypeptide hormones, proteolytic cleavage occurs at 
paired basic residues; this cleavage is mediated by a subset 
of enzymes in the subtilisin-like  enzyme family, known as 
the prohormone convertases (PCsl; for review see Hutton, 
1992; Seidah and Chretien, 1992; Steiner et al., 1992). A1- 
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though much information is available  regarding the bio- 
chemistry and distribution of the PCs, the biosynthesis and 
regulatory aspects  of these enzymes are not fully under- 
stood. The removal of the pro sequence in PC1 appears to 
occur rapidly and autocatalytically  (Benjannet et al., 1993; 
Lindberg, 1994; Milgram and Mains, 1994; Zhou and Lind- 
berg, 1993; Goodman and Gorman, 1994). The processing 
of proPC2,  on the other hand, is considerably slower than 
that of proPC1  (Benjannet et al., 1993; Guest et al., 1992; 
Shen et al., 1993; Zhou and Mains, 1994), and a substantial 
amount of proPC2  is stored as such in many cell  lines 
(Lindberg et al., 1994; Zhou and Mains, 1994). Since PC2 
is thought to cleave intermediates produced by PC1 during 
peptide processing  (Benjannet et al., 1991; Thomas et al., 
1991; Breslin et al., 1993; Zhou and Mains, 1994), the regu- 
lation of availability of active PC2 could represent an im- 
portant controlling step in peptide hormone production. 
The 7B2 protein, which was first isolated from porcine 
and human pituitary glands over a decade ago, is selec- 
tively distributed in the central nervous system and in en- 
docrine tissues (Hsi et al., 1982; Seidah et al., 1983; Iguchi 
et al., 1984). The predominant form of this protein stored 
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search  has  shown  that  in  Xenopus  intermediate  lobe, 
newly synthesized 27-kD  7B2  can be coimmunoprecipi- 
tated with proPC2 using PC2 antiserum (Braks and Mar- 
tens,  1994).  In  line with  the  idea that  7B2 represents a 
PC2-binding  protein, the  amino-terminal  region  of 7B2 
(residues 1-90 of mature 7B2) shares weak amino acid se- 
quence similarities with members of the 60-kD subclass of 
molecular chaperones, such as human, wheat, and E. coli 
chaperonin-60  (Braks  and  Martens,  1994).  Interestingly, 
the carboxy-terminal portion of 7B2 is distantly related to 
a family of subtilisin inhibitors known as the potato inhibi- 
tor I family, and our in vitro experiments have shown that 
intact 27 kD 7B2, but not the processed 21-kD product, 
represents a potent and specific inhibitor of PC2 (Martens 
et al., 1994).  We have recently demonstrated that the in- 
hibitory activity of 27 kD 7B2 resides entirely within the 
carboxyl-terminal 31  amino  acid  peptide  removed upon 
maturation of 7B2 to its 21-kD form (Lindberg et al., 1995; 
Van Horssen et al., 1995). Taken together, these observa- 
tions suggest an important role for 7B2 in the maturation 
of proPC2 as well as in the regulation of PC2 activity. To 
clarify the nature of the interaction of 7B2 and PC2, we 
have transfected various rat 7B2 constructs into two neu- 
roendocrine cell lines and examined the kinetics of pro- 
PC2 maturation. In addition, we have used PC2-express- 
ing AtT-20 and CHO cells to directly demonstrate a role 
for 7B2 in the generation of enzymatically active PC2. 
Materials and Methods 
Construction  of 7B2 Vectors 
Rat 7B2 cDNA (obtained from J. E. Dixon; Waldbieser et al., 1991)  was 
subcloned directly into the BamHI and HindIII sites of pCEP4 (Invitro- 
gen), immediately downstream of the  CMV  promoter,  using standard 
methods.  Other  truncations and  mutations of 7B2 were  generated  by 
PCR-mediated methods using the rat 7B2 cDNA mentioned above and 
cloned into the BamHI-HindIlI sites of pCEP4. The primers used in each 
construction were for the 1-90 amino acid truncation: 5'-GGCGCAAG- 
CTTCACCATGACCTCAAGGATGG-3' and 5'-CGGCGGGATCCT- 
TAATTTGGAGGGTCTGGGTA; for the 21-kD construct, 5'-GGCG- 
CAAGCTTCACCATGACCTCAAGGATGG-3' and 5'-CCGGCGGG- 
CCCGGATCCqTACTGTCCTCCCTTCATC-3'. 
The resulting PCR products were digested with BamHI and HindIII 
and ligated into pCEP4. 
The cleavage blockade mutant of 7B2 was created by a two-step PCR 
method, as described by Vallette et al. (1989). The following primers were 
used: 5'-GGCGCAAGCTTCACCATGACCTCAAGGATGG-3',  5'-GTT- 
GCTG'Iq?Cq?GGCTCTGTCCTCCC'Iq'CAT-3  ', 5'-AGCCAGAACAGC- 
AACAGTGTCAATCCCTATC-3' and 5'-CGGCCGGATCCTTATTC- 
TGGCTCCTTCTC-3'. 
The second and third primers contained the desired mutations (elimi- 
nation of the pentabasic processing site). The first and second primers 
were used as a pair in one reaction; and the third and the fourth in a sepa- 
rate reaction in the first round of PCR. In the second round of PCR, the 
resulting two individual fragments were purified and mixed, and then am- 
plified using the first and the fourth primers. This fragment was then di- 
gested with BamHI and HindIII, and ligated into pCEP4. All inserts de- 
rived from PCR were verified by DNA sequencing. 
Cell Culture,  Transfection,  and Selection 
An AtT-20 cell line stably expressing PC2 (Zhou and Mains, 1994)  was 
kindly provided by Dr. R. E. Mains (Baltimore, MD); this cell line served 
as the host for transfection of 7B2 cDNAs described below. Data were 
confirmed in Rin/PE cells (a derivative of the rat insulinoma Rin5f which 
has been stably transfected with rat proenkephalin cDNA; Lindberg, I., 
unpublished results). Rin5f cells were obtained from Dr. Gary Thomas 
(Portland, OR). 
All cell culture media were obtained from GIBCO-BRL (Gaithers- 
burg, MD); ceils were cultured at 37°C in an atmosphere of 5% CO2. Cul- 
ture medium used for AtT-20/PC2 ceils consisted of DMEM high glucose 
medium containing 10% Nuserum, 2.5% FBS and 200 ~g/ml G418, while 
Rin/PE cells were cultured in low glucose DMEM containing 10% FBS 
and 500 ~g/ml G418. CHO/PC2 cells, which represent a CHO cell line am- 
plified for the expression of mouse PC2 using the dihydrofolate reduc- 
tase-coupled method (Shen et al., 1993),  were grown as previously de- 
scribed. 
Transfection  of  each  cell  line  was  accomplished  with  Lipofectin 
(GIBCO/BRL).  Briefly, ~1  ×  106 cells in a  10-cm plate were used for 
each transfection. The cells were incubated in 3 ml Optimem (GIBCO/ 
BRL) containing 30 Ixg vector DNA and 30 Ixg Lipofectin for 5 h at 37°C 
followed by the addition of 7 ml growth medium containing 100 izg/ml hy- 
gromycin (Sigma Chem. Co., St. Louis, MO). Approximately 2 wk later, 
10-30 hygromycin-resistant  colonies were picked and screened for 7B2 ex- 
pression either by Western blotting, by radiolmmunoassay or by radiola- 
beling  and  immunoprecipitation.  Generally,  the  first  experiment  em- 
ployed the two highest-expressing  clones, while confirmatory experiments 
employed  only  the  highest-expressing clone.  7B2-expressing cell  lines 
were found to be quite stable and could be passaged for three months 
without apparent alteration in expression levels. 
Metabolic Labeling and Immunoprecipitation 
Half a million cells/weU in a six-well plate were labeled with [35S]methio- 
nine-labeling mix (Amersham Corp., Arlington Heights, IL) in methio- 
nine-deficient DMEM, or with Trans-label Mix (ICN Biomedicals, Costa 
Mesa, CA) in methionine- and cysteine-deficient DMEM. The cells were 
pulsed for 10 or 20 rain and chased for the indicated times before being 
subjected to immunoprecipitation. Cells were boiled for 5 rain in 0.1  ml 
boiling buffer (50 mM Na-phosphate, pH 7.4, 1% SDS, 50 mM 15 mercap- 
toethanol, and 2 mM EDTA). These samples were then diluted with 0.9 
ml AG buffer (0.1 M Na-phosphate, pH 7.4,  1 mM EDTA, 0.1% Triton, 
0.5% NP-40, and 0.9% NaC1) for immunoprecipitation. The samples (0.5 
ml each) were preincubated with 0.1 ml 20% Protein A-Sepharose CL-4B 
(Pharmacia, Sweden, previously hydrated and washed three times with 
AG buffer)  for  1  h, and  then centrifuged. Antiserum (5  ILl) was then 
added to the supernatant, along with 25 g.l of I0 mM PCMS (p-chloromer- 
curiphenylsulfonic acid) and 25 izl of 100 mM PMSF, and incubated for ei- 
ther 6 h  or overnight at 4°C. Protein A-Sepharose (100 Ixl of 20%, hy- 
drated  and  washed  three  times with  AG  buffer)  was  added  and  the 
samples rocked at 4°C for 1 h. The samples were then washed two times 
with AG buffer, once with 0.5 M NaCI in PBS, and once with PBS. Immu- 
noprecipitates were resuspended in Laemmli sample buffer and analyzed 
using either 8.8% (for PC2) or 15% (for 7B2) SDS-PAGE. The quantita- 
tive nature of the immunoprecipitation was verified by immunoprecipitat- 
ing spent extracts; no further 7B2 nor PC2 forms were recoverable after a 
second round of immunoprecipitation. A  similar procedure was used in 
the coimmunoprecipitation of 7B2  and proPC2,  except that cells were 
lysed by  scraping into  AG  buffer  and  were  frozen  and  thawed  once 
at-20°C; samples were not boiled before immunoprecipitation. All label- 
ing experiments/immunoprecipitations were  repeated  at  least once,  on 
separate preparations of cells. 
The procedure for SDS-PAGE (8.8% gel for analysis of PC2 immuno- 
precipitations, 15%  for 7B2 immunoprecipitations) has been previously 
described (Shen et al., 1993). After electrophoresis, gels were treated with 
Entensify (DuPont, New England Nuclear, Wilmington, DE)  following 
the manufacturer's recommendation before fluorography. Quantitation of 
radioactivity within each band was carried out using a Phospholmager and 
ImageQuant software (Molecular Dynamics, Sunnyvale, CA). 
7B2 Radioimmunoassay 
Polyclonal antiserum to the sequence 7B223.39 (Iguchi et al., 1983)  conju- 
gated to keyhole limpet hemocyanin was raised in rabbits (Hazleton JRH, 
Denver, PA). 7B223.39 was purchased from Peninsula (Belmont, CA) for 
use  as  standard  and  as  radiolabel.  The  peptide  was  iodinated  using 
chloramine T and purified on a C-18 Sep-Pak cartridge. The radioimmu- 
noassay was carried out overnight in duplicate using antiserum diluted 1: 
30,000,  10,000 cpm of iodinated peptide, and samples in a total volume of 
300 ~1 RIA buffer (0.1  M sodium phosphate, pH 7.4,  50 mM NaCI, con- 
taining 0.1% BSA and 0.1% sodium azide. 50-1xl duplicate samples of con- 
ditioned medium were diluted 1:1 with RIA buffer and heated to 100°C 
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say. Standards were prepared in Optimem (GIBCO/BRL): RIA buffer in 
a 1:1 ratio. Free radiolabel was separated from bound using polyethylene 
glycol precipitation  (as  described  in  Mathis  and  Lindberg,  1992).  The 
range of the standard curve was 1-500 fmol and the IC50 was 42 fmol. 
Collection of Conditioned Medium from AtT-2OIPC2 
and CHO Cells and Enzyme Assay 
Subclones of AtT-20/PC2 cells expressing either no 7B2, 21 kD 7B2, 27 
kD 7B2, the pentabasic blockade mutant, and the amino-terminal domain 
were subcultured at 500,000 cells per well in a 6-well plate. The following 
day, the wells were washed twice with 5  ml of Optimem and then incu- 
bated with 1 ml of Optimem containing 100 I~g/ml aprotinin (Miles) over- 
night. The conditioned medium was removed from each well, centrifuged 
to remove any floating cells, and 35-50-~1 aliquots then subjected to ra- 
dioimmunoassay  for 7B2 (in duplicate) and enzyme assay for PC2 (in du- 
plicate). Specificity of the enzymatic reaction was monitored in separate 
reactions containing 100 IxM synthetic 7B2 carboxy-terminal peptide (hu- 
man sequence, residues 155-185),  which represents a PC2-specific inhibi- 
tor (Martens et al., 1994;  Lindberg et al., 1995).  The experiment was re- 
peated once with similar results. 
For the clonal comparison study, various CHO/PC2-7B2 clones were 
isolated and subcultured to approximately similar confluence (70-80%) in 
a  12-well plate. After two 2-ml washes with Optimem, 1 ml of Optimem 
containing 100 ~g/ml aprotinin was placed on each well and the plate was 
returned to the incubator for 16 h. The following morning, medium was 
collected from each well, centrifuged at low speed to remove any floating 
cells, and subjected to radioimmunoassay  for 7B2 and enzyme assay. 
For the comparison of the two best 7B2-expressing CHO clones with 
the parent cell line, 35-txl duplicate aliquots of 6  h  conditioned medium 
(80%  confluent 35-mm dish with  1 ml Optimem, containing 100 ~g/ml 
aprotinin) were incubated in the reaction mixture described above (with 
or without 100 IxM 7B2 CT peptide) for 16 h. The production of free ami- 
nomethylcoumarin (AMC)  from clones expressing 7B2 was linear over 
time. To observe potential activation of proPC2 in the control CHO/PC2 
cell line by exogenous 7B2, recombinant rat 7B2 was prepared by bacte- 
rial expression (Martens et al., 1994)  and included in the medium as de- 
scribed above at a concentration of 100 i~g/ml (5.4 I~M) during a 16-h incu- 
bation at 37°C; a parallel control culture received an equivalent amount of 
bovine serum albumin. The following day the medium was removed, cen- 
trifuged, and tested for enzymatic activity. The experiment was repeated 
once with similar results. 
The assay for PC2 (Lindberg et al., 1992) was carried out using 35 p~l of 
each conditioned medium sample in a  total volume of 50 ~1, containing 
0.1M sodium acetate, pH 5.0, 5 mM calcium, 0.1% Brij 35, 2 p~g of bovine 
serum albumin, an inhibitor mix (1  p~M pepstatin A, 100  p.M  tosyllysyl 
chloromethylketone; 100 p~M tosyl phenylalanylchloromethyl ketone, and 
1 ~M E-64) and a final concentration of 200 IxM Cbz-Arg-Ser-Lys-Arg- 
aminomethylcoumarin substrate. The liberation of the highly fluorescent 
product AMC was monitored by fluorescence spectroscopy (380 excita- 
tion, 460 emission). 
106 cells (the limit of detection of the assay), while the best 
transfected cell line contained 120 fmol 7B2/106 cells. Met- 
abolic-labeling  experiments  with  [35S]methionine  were 
carried out on these cells as well as the parent AtT-20/PC2 
cell line. In agreement with the results of Braks and Mar- 
tens  (1994),  when cell extracts were immunoprecipitated 
with PC2 antiserum, 27 kD 7B2 was observed to coimmu- 
noprecipitate with proPC2 (Fig.  1).  After excision of the 
bands corresponding to proPC2 and 7B2 and estimation of 
the  radioactivity in  each, the molar ratio of proPC2 and 
7B2 was found to be approximately 1.1:1.0 when the num- 
ber of methionines  in  each molecule was taken into  ac- 
count (Table I). 
7B2 Facilitates proPC2 Maturation in AtT-20/PC2 and 
RinPE Cells 
We next performed a  kinetic analysis of proPC2 matura- 
tion in control and 7B2-transfected AtT-20 cells. To avoid 
the possibility of conversion of proPC2 to PC2 during the 
overnight immunoprecipitation, we harvested the cells in 
the presence of SDS (Milgram and Mains,  1993),  boiled, 
and then diluted this material into nonionic detergent for 
immunoprecipitation. Fig. 2 A  shows the results of an ex- 
periment  in  which  AtT20/PC2-r7B2  or  control  AtT-20/ 
PC2  cells  were  pulsed  for 20  min  with  [35S]methionine, 
then either terminated (lane 0) or further incubated for 1, 
2, 3, or 4 h in the presence of unlabeled methionine. This 
figure demonstrates that the presence of 27 kD 7B2 dra- 
matically facilitated the maturation rate of proPC2. Using 
phosphorimage analysis, we estimate that the half-life of 
the newly synthesized proPC2 in 7B2-expressing cells was 
1.7 h, whereas in parent cells the half-life was 2.7 h. Similar 
Results 
AtT-20/PC2-7B2 Cells Express 7B2 which 
Coimmunoprecipitates with  proPC2 
Braks and Martens (1994) have demonstrated colmmuno- 
precipitation of 27 kD 7B2 with proPC2 in the Xenopus- 
intermediate  pituitary.  To  investigate  the  nature  of this 
association in a cell culture system, which offers more ex- 
perimental  control,  we  stably  transfected  PC2-overex- 
pressing AtT-20 cells (Zhou et al.,  1993;  kindly provided 
by R. E. Mains) with a  hygromycin resistance-conferring 
construct  containing  rat  7B2  cDNA.  7B2-expressing 
clones were selected by Western blotting, which revealed 
normal cleavage of the transfected 27-kD 7B2 precursor to 
the 21-kD product (results not shown). Using radioimmu- 
noassay,  the  expression  level of endogenous  7B2  in  the 
parent cell line was estimated to be at or less than 10 fmol/ 
Figure 1.  27 kD 7B2 coimmunoprecipitates with proPC2. AtT20/ 
PC2 and AtT20/PC2-7B2 cells were pulsed with [35S]methionine 
for 20 min. Cell extracts, prepared in AG  buffer, were immuno- 
precipitated  with PC2  antiserum and subjected to electrophore- 
sis. The bands corresponding to  PC2 and 7B2 were  excised and 
the  radioactivity  in  each  was  determined  using  a  scintillation 
counter. The results are shown in Table I. 
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Coimmunoprecipitated proPC2 and 7B2 
Clone #1  Clone #2 
PC2  7B2  PC2  7B2 
CPM  4790  1010  5130  1050 
No. of Met  16  3  16  3 
Molar ratio  1  1.12  1  1.09 
results were obtained in one other independently derived 
clone. 
We also found that the rate of secretion of mature PC2 
was increased in cells transfected with 7B2 (Fig. 2 B). De- 
spite  this  increased  secretion,  analysis  of steady-state  la- 
beling  of  control  and  7B2-expressing  cells  revealed  in- 
creased  storage  of  mature  PC2  in  7B2-expressing  lines 
(Fig. 2  C). However, analysis of the kinetics of processing 
of  newly  synthesized  proopiomelanocortin  (POMC)  in 
AtT-20/PC2-7B2 cells did not reveal any detectable differ- 
ences  from  the  parent  cell  line  (Mains,  R.  E.,  personal 
communication). 
The AtT-20/PC2 cell line has been obtained through ar- 
tificial engineering of AtT-20 cells with PC2 cDNA (Zhou 
and Mains, 1993). To extrapolate these results to a cell line 
which  naturally  expresses  PC2,  we  performed  a  similar 
overexpression of 7B2 in RinPE cells,  a  derivative  of the 
rat insulinoma cell line Rin5f which has been stably trans- 
fected with rat proenkephalin cDNA (Lindberg, I., unpub- 
lished results). The parent cell line is known to synthesize 
large  quantities  of PC2  (Shen  et  al.,  1993).  Fig.  3  shows 
that the presence of transfected 27 kD 7B2 in these  cells 
was also able  to facilitate  the maturation  of proPC2.  No 
Figure 3.  27  kD  7B2  facilitates  the  maturation  of proPC2  in 
RinPE cells. RinPE-7B2 or control RinPE cells were pulsed for 
20 min with [35S]methionine and then either terminated (lane 0 h) 
or chased for 2 h (2 h). M, 2-h chase medium. 
differences  in the  initial  processing of newly synthesized 
proenkephalin  to  Peptide  B/Met-enk-Arg-Phe  could  be 
detected between RinPE cells and RinPE-7B2 cells (Blake, 
A,, and I. Lindberg, unpublished results). 
Structure-Function Analysis of 7B2 Indicates a 
Requirement for the Full 21-kD Protein 
Braks and Martens  (1994) have previously proposed that 
the binding of proPC2 to 7B2 is mediated by an amino-ter- 
minal domain weakly homologous to a chaperonin-related 
domain; this domain was proposed to extend to residue 90. 
To examine whether this region was sufficient to account 
for the effects on proPC2 transport, we constructed an ex- 
pression  vector containing this  region for transfection  of 
AtT-20/PC2  cells.  Clones  expressing  this  construct  were 
selected using a  radioimmunoassay against  an amino-ter- 
minal  epitope  of 7B2.  Fig.  4  depicts  the  maturation  of 
proPC2 in 1-90 7B2 and 27 kD 7B2 cells as well as in the 
Figure 2.  27 kD 7B2 facilitates  the maturation of proPC2in AtT-20/PC2 
cells. AtT20/PC2-7B2 or control AtT-20/PC2 cells were pulsed for 20 min 
with [35S]methionine, then either terminated (lane 0) or chased for 1, 2, 3, 
or 4 h. Cell extracts were boiled for 5 min in the presence of 1% SDS and 
50 mM-mercaptoethanol. These samples were then diluted 10× with 1% 
NP-40 for immunoprecipitation with PC2 antiserum. A shows that the rate 
of proPC2 processing was increased in 7B2-transfected cells. B depicts the 
effect of 7B2 expression on the secretion of mature PC2. C shows the ratios 
of intracellular proPC2 to mature PC2 at 6 h in a steady-labeling experi- 
ment. 
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proPC2 processing. Overexpression  of the proposed chaperone 
domain (Braks and Martens, 1994) had no effect on PC2 matura- 
tion in AtT-20/PC2 cells. AtT20/PC2 (lanes I and 4), AtT20/PC2- 
7B2 (lanes 2 and 5), and AtT20/PC2-NT 7B2 (lanes 3 and 6) were 
pulsed for 20 min (lanes 1-3) or pulsed and then chased for 2 h 
(lanes 4--6). The samples were boiled as described before immu- 
noprecipitation.  Truncated 7B2 (NT-7B2) could not be coimmu- 
noprecipitated with PC2 (not shown). 
parent cell line; no detectable effects of 1-90 7B2 were ob- 
served.  In  independent  experiments, the  remaining  car- 
boxy-terminal  region  of  7B2  (7B295.185) was  similarly 
transfected into AtT-20 cells; again, no effect on proPC2 
maturation was observed (results not shown). Using PC2 
antiserum, no coimmunoprecipitation of either 7B21.90 or 
7B295.185 with PC2 was observed (data not shown). Simi- 
larly to the result obtained using intact 7B2, no effects on 
POMC processing were detected in either the 7B21.90 or 
the 7B295.185-expressing cell lines (Mains, R. E., personal 
communication). 
The mature form of 7B2, 21-kD 7B2, represents the pre- 
dominant form of this peptide stored within neuroendo- 
crine cells (Iguchi et al., 1984; Hsi et al.,  1984; Ayoubi et 
al., 1990; Paquet et al.,  1994).  We therefore transfected a 
construct containing this region into AtT-20/PC2 cells. Fig. 
5 depicts the maturation of proPC2 in cells containing this 
construct. The results of this 2-h pulse-chase experiment 
show that the 21-kD 7B2 protein is able to efficiently facil- 
itate proPC2 cleavage. Further analysis revealed that  in 
cells transfected with 21 and 27 kD constructs, the kinetics 
of proPC2 cleavage and the kinetics of secretion of PC2 
are  identical  (results  not  shown).  These  results  suggest 
that the functional region of 7B2 which accomplishes the 
Figure 5.  The 21-kD form of 7B2 facilitates  the maturation of 
proPC2. AtT20/PC2, AtT20/PC2-7B2 (27 kD 7B2), and AtT/20/ 
PC2-N560 7B2 (21 kD 7B2) cells were pulsed with [35S] methio- 
nine for 20 min or pulsed and then chased for 2 h. 
facilitation of proPC2 cleavage is entirely included within 
the first 156 amino acids. 
Blockade of Cleavage of  27 kD 7B2 Results in a 
Molecule which Cannot Facilitate proPC2 Maturation 
To investigate whether the cleavage of 27 kD 7B2 to 21 
kD 7B2 and the carboxy-terminal peptide is obligatory for 
the facilitatory function of 7B2, and the role the carboxy- 
terminal  peptide  plays  in  the  binding  of  7B2  to  PC2/ 
proPC2,  we  mutated  the  normal  cleavage site  (residues 
151-155) from RRKRR to SQNSN and transfected AtT20/ 
PC2 cells with the construct. Fig. 6, panel A  (denatured 
immunoprecipitate using 7B2 antiserum) shows that this 
7B2 mutant protein is expressed in transfected cells (lane 
0); it was not processed intracellularly but instead was rap- 
idly secreted. At 2 h no intracellular 7B2 remained (lane 2; 
no visible band). Fig. 6, panel B, which represents a non- 
denaturing coimmunoprecipitation of medium obtained at 
2 h of chase (7B2 antiserum), shows that the mutant pro- 
tein was secreted not as the 21-kD form, but as the 27-kD 
form, supporting the  idea  that  the  normal cleavage site 
was  blocked. This figure further shows  that  this  mutant 
7B2 protein can efficiently coimmunoprecipitate proPC2. 
It is interesting that both proPC2 as well as the unproc- 
essed  mutant  27-kD  7B2  were  secreted  intact  into  the 
growth medium  (panel B); the secretion of proPC2 was 
not  observed in  experiments with  other 7B2-expressing 
cell lines.  It is likely that  this  proPC2/noncleavable 7B2 
complex cannot be further processed by the cellular ma- 
chinery and is secreted as such. Fig. 6, panel C depicts a 
pulse-chase  experiment  of  PC2  maturation  in  AtT-20/ 
PC2-blockade  mutant  cells showing that  this  unprocess- 
able  7B2  mutant  cannot  facilitate  the  maturation  of 
proPC2. We conclude that proteolytic processing of 27 kD 
7B2 is required for its facilitatory function. 
Kinetics of 7B2 Processing in AtT2OIPC2-7B2 Cells 
While the maturation of proPC2 in AtT-20/PC2-TB2 cells 
is rather slow (with a half time of ~1.7 h  in 7B2-overex- 
pressing cells), the conversion of 27 kD 7B2 to 21 kD 7B2 
occurred much more quickly. After 30 min of chase, virtu- 
ally  all  of the  newly synthesized  27  kD  7B2  had  been 
cleaved (Fig. 7, panel A). Furthermore, the secretion of 21 
kD 7B2 was also much faster than that of PC2; even at 20 
min,  21  kD  7B2  was  detectable in  the  medium  (Fig.  7, 
panel B). At 120 min of chase, however, ~1/3 of the newly 
synthesized 21  kD  still remained inside  the cells (Fig. 7, 
panel A), as judged from phosphorimage analysis. 
7B2 Is Synthesized and Secreted More Rapidly 
than PC2 
To calculate the relative synthesis rates of 7B2 and PC2, 
AtT-20/PC2-7B2 cells were labeled with  [35S]methionine 
for 20 min. The cells were then extracted using 1%  SDS 
and 50 mM 13-mercaptoethanol and boiled. Half of the ex- 
tract was immunoprecipitated with 7B2 antiserum, and the 
other half immunoprecipitated with PC2 antiserum. The 
resulting samples were then resolved by SDS-PAGE and 
visualized by fluorography. The 27/21-kD 7B2 bands and 
the  proPC2  band  were  excised, the  radioactivities mea- 
Zhu and Lindberg  7B2 FacilitatesproPC2 Conversion  1645 Figure 6.  Expression of a 7B2 blockade mutant (which cannot be 
cleaved to 21 kD mature 7B2) prevents the facilitated maturation 
of proPC2 in AtT-20/PC2  cells. A  shows the lack of processing 
and rapid secretion  of 7B2 in AtT-20/PC2  cells expressing  the 
7B2 blockade mutant at 0 and 2 h of chase. B depicts the coimmu- 
noprecipitation of 27 kD blockaded 7B2 and proPC2 in the me- 
dium (2 h chase time). C shows a time course of proPC2 process- 
ing in AtT-20/PC2 (lanes 1 and 4), AtT-20/PC2-7B2 (lanes 2 and 
5), and AtT-20/PC2-7B2 blockade (lanes 3 and 6). Lanes 1-3 rep- 
resent cells pulsed for 20 rnin, and lanes 4--6 represent cells har- 
vested after 2 h of chase. 
sured, and the molar ratio of the two molecules was calcu- 
lated, taking the number of methionines in each molecule 
into  account  (the  21- and  27-kD  forms of 7B2  have the 
same number of methionines). These results revealed that 
the synthesis rate of 27 kD 7B2 is greater than that of PC2; 
for every 3.6  _+  0.3  7B2 molecules synthesized, only one 
proPC2 molecule was produced (mean _+ SD of three de- 
terminations).  However, in  a  6-h steady labeling experi- 
ment, the intraceUular molar ratio of all forms of these two 
molecules  (predominantly 21  kD  7B2  and  proPC2)  was 
only 1.4:1.0.  Therefore, relative to PC2, 7B2 must be dis- 
proportionately rapidly secreted. 
Secretion of  PC2 Activity from AtT-20/PC2 Cells 
Occurs only in Cells Transfected with 21 or 27 kD 7B2 
The  above  results  demonstrate  that  7B2  interacts  with 
proPC2 to facilitate the maturation of this enzyme precur- 
sor. However, these results do not reveal whether this pro- 
teolytic processing event is associated with the production 
of active enzyme; indeed, the lack of effect on POMC pro- 
cessing could be interpreted as implying that 7B2 overex- 
pression  does  not  result  in  the  net  generation  of active 
PC2.  We  therefore  measured  the  release  of active PC2 
into  the  medium from AtT-20/PC2  cell  lines  expressing 
the various forms of 7B2.  We were not  able to measure 
significant levels of activity in short-term basal medium or 
medium  from  phorbol  ester-stimulated  cells;  however, 
overnight-conditioned medium yielded measurable levels 
of PC2 activity (Fig. 8). Only cells transfected with 27 or 21 
kD 7B2 were able to secrete active PC2 into the medium. 
The origin of this enzymatic activity as PC2 was confirmed 
through its ability to be blocked by the PC2-specific inhib- 
itor, h7B2155.185 (Lindberg et al., 1995). 
In CHO/PC2 Cells, Expression of  2I kD 7B2 Results 
in the Generation of  Ezymatic Activity 
To  confirm  the  above  results  in  a  constitutive  cell  line 
which potentially offered a greater ability to measure PC2 
activity, we tested the effect of 7B2 expression on the pro- 
duction of enzymatically active PC2 from CHO cells am- 
plified for mouse PC2 expression using the dihydrofolate 
reductase-coupled method (Shen et al., 1993). These cells 
have previously been shown to produce large quantities of 
proPC2 which is slowly secreted into the medium and is 
enzymaticaUy inactive (Shen et al., 1993). CHO/PC2 cells 
were transfected with the expression vector containing 21 
kD 7B2 described above and clones selected on the basis 
of secretion  of immunoreactive 7B2.  Table  II shows  an 
analysis of cleavage of the fluorogenic substrate Cbz-Arg- 
Ser-Lys-Arg-aminomethyl  coumarin  by  medium  condi- 
tioned for only 6 h by control CHO/PC2 cells or by two in- 
The Journal of Cell Biology,  Volume 129, 1995  1646 Figure 7.  Kinetics of maturation and secretion  of 7B2. AtT20/ 
PC2-7B2 cells were pulsed with [35S]methionine  for 10 min and 
chased for the times indicated. A shows that the conversion of 27 
kD 7B2 to the 21-kD form is completed within 30 min; B shows 
the kinetics of secretion of 7B2 into the medium; secretion of ma- 
ture 7B2 (21 kD) occurred within 20 min. 
dependent clones expressing 21 kD 7B2. As expected from 
previous results,  medium  obtained from non-7B2-trans- 
fected  CHO/PC2  cells was  enzymatically inactive;  how- 
ever, medium derived from each of the two 21-kD 7B2- 
expressing clones exhibited extremely high levels of activity. 
A high degree of correlation of secreted PC2 activity with 
7B2  expression was  observed using  independent  clones 
(Fig. 9). Incubation of CHO/PC2 cells overnight with 100 
izg/ml recombinant rat 21 kD 7B2 did not result in the gen- 
eration of detectable enzymatic activity in the conditioned 
medium (not shown). 
Discussion 
The proteolytic activation of PC2 has been the subject of 
several previous investigations.  Studies using  oocyte ex- 
tracts  and  site-directed mutants  of proPC2  have  shown 
that the conversion of proPC2 (75 kD) to mature PC2 (64 
kD)  is  autocatalytic, and  that  it  is  apparently  mediated 
through  an  intermolecular  reaction  which  is  extremely 
slow in this system (Matthews et al., 1994; Shennan et al., 
1995). In previous experiments using a CHO cell overex- 
pression system, we were unable to demonstrate any auto- 
catalysis of proPC2, and proPC2 was largely secreted as an 
intact, inactive form (Shen et al., 1993). Efforts to activate 
proPC2 in vitro, for example using recombinant PC1, were 
not successful (Zhou, Y., and I. Lindberg, unpublished re- 
sults). These findings strongly implied that PC2 required a 
separate cofactor, either for activation or activity; or, as 
suggested by Braks and Martens (1994), that PC2 required 
the presence of another protein, namely 7B2, for proper 
folding. The results presented above provide experimental 
support for the involvement of 7B2 in proPC2 activation. 
Our data demonstrate that 27 kD 7B2 can be coimmuno- 
precipitated with proPC2 using anti-PC2 antiserum in ex- 
tracts  of 7B2-overexpressing, PC2-containing  cells,  con- 
firming  the  similar  association  reported  by  Braks  and 
Martens (1994) in Xenopus pituitary. In addition, this as- 
sociation  is  correlated  with  a  profound  acceleration  of 
maturation of proPC2 to mature PC2 in cells expressing 
7B2, with a half-life decreasing from ~2.7 h-l.7 h. The ob- 
servation of stoichiometric binding  of proPC2 to 27 kD 
7B2 further supports the idea that 7B2 represents a PC2- 
binding protein involved in the maturation of proPC2 to 
PC2. 
We found that proPC2 required 2-3 h for half-maximal 
conversion to mature PC2 in AtT-20/PC2 cells; these ki- 
netics are in good agreement with those obtained by Zhou 
and Mains (1994) for the same cell line. Similarly slow pro- 
cessing of proPC2 was observed in other neuroendocrine 
cell lines and in rat pancreatic islets  (Guest et al.,  1992; 
Shen et al.,  1993; Benjannet et al.,  1993;  Shennan et al., 
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Figure 8.  Secretion  of PC2  activity  in AtT-20/PC2  cell lines is 
correlated with the expression of certain forms of 7B2. (Hatched 
bars) Cell lines expressing (from left to right) no 7B2 (control), 27 
kD 7B2, 21 kD 7B2, the blockade mutant (block), and the amino- 
terminal domain (amino). Clear bars to the right of each hatched 
bar indicate activity measured in the presence of the PC2 inhibi- 
tor  h7B2155.185 (Lindberg  et  al., 1995). Cells  were  plated  at 
500,000 cells/well in a six-well plate; 2 d later, serum-free medium 
was placed on the cells and assayed in duplicate the following day 
for the expression of enzymatic activity. The total amount of im- 
munoreactive 7B2 in the conditioned medium was 440 fmol (con- 
trol); 790  fmol,  27  kD  7B2; 770  fmol,  21  kD  7B2; 452  fmol, 
blockade mutant (block); and 530 fmol, amino-terminal domain 
(amino). Variance between duplicates was always less than 5 %. 
1995).  (An exception may exist for Xenopus intermediate 
lobe, in which proPC2 appears to be cleaved much more 
rapidly than in neuroendocrine cell lines and in pancreatic 
islets;  Braks  and  Martens,  1994).  Previous  studies  from 
several laboratories have shown that the subcellular site of 
conversion of proPC2 to mature PC2 is likely to be a late 
secretory  granule  compartment  such  as  the  trans-Golgi 
network  or  immature  secretory  granules  (Guest  et  al., 
1992;  Shen et al., 1993; Zhou and Mains, 1994; Braks and 
Martens, 1994; Shennan et al., 1995). Similarly, 27 kD 7B2 
is  converted to  the  21-kD  form in  a  brefeldin-sensitive, 
late secretory pathway cellular compartment, most proba- 
bly by furin (Paquet et al., 1994). The fate of the remaining 
carboxy-terminal  31  amino  acids  of 7B2  which  repre- 
sents  the  inhibitory  peptide  is  uncertain.  This  peptide 
could be recovered intact from AtT-20 cells (Paquet et al., 
1991); however, it may also be proteolyzed in certain tis- 
sues since Sigafoos et al. (1993) have described the isola- 
tion of a carboxy-terminal fragment of this peptide from 
bovine adrenal medullary granules. 
Confirming  previous  results  obtained  by  Braks  and 
Martens  (1994)  and  Paquet  et  al.  (1994),  we  observed 
rapid maturation of newly synthesized 27 kD 7B2 (tl/2 = 
15 min).  In AtT-20/PC2 cells, secretion of newly synthe- 
sized 7B2 into the medium was also unexpectedly rapid, in 
contrast  to  results  obtained  using  vaccinia virus  vectors 
(Paquet  et  al.,  1994)  and  Xenopus  intermediate  lobe 
(Braks and Martens, 1994). We found that following only 
20 min of chase, newly synthesized 21  kD 7B2 could al- 
ready be detected in the medium, and by 120 min, only a 
third of the labeled 7B2 protein remained inside the cells; 
Table II. Only CHO/PC2 Cells Expressing 21 kD 7B2 Exhibit 
PC2 Activity* 
pmol AMC generated/16h/35 wl 6 h conditioned medium 
Parent CHO/PC2  21 kD 7B2#7  21 kD 7B2#20 
Control  58  700  667 
+PC2 inhibitor  62  58  48 
* 70-80% confluent 35 nun wells of two 21-kD 7B2-transfected  cell lines and the par- 
ent, nontransfected cell line were incubated with Optimem for 6 h. The conditioned 
medium was then removed, centrifuged, and assayed in duplicate for PC2 activity as 
described in the text. The specific PC2 inhibitor used was h7B2155.lSS  (Lindberg et al., 
1995).  Control reactions containing only Optimem (not conditioned by cells) con- 
tained 58 pmol AMC. Variance between duplicates was always less than 5%. 
this remaining 7B2 may represent the pool which binds to 
proPC2. Expression of 7B2 also increased the rate of se- 
cretion of mature PC2 from the cells; however, not all of 
the  additional  mature PC2  produced  by 7B2  expression 
was secreted since the steady state intracellular content of 
mature  PC2  was  slightly,  but  consistently,  increased  in 
7B2-expressing cells. 
Based  upon  homology  with  chaperonins,  Braks  and 
Martens (1994) suggested that the first 1-90 amino acids of 
7B2  would  represent  the  putative  "chaperone  domain." 
Our data showing that expression of this protein is not suf- 
ficient to facilitate proPC2 cleavage indicates that further 
structural  information must be required.  We found that 
expression of the first 151 amino acids, which encode the 
21-kD natural processing product of 7B2, were sufficient 
for the facilitation of proPC2 processing. These data indi- 
cate an affinity of this truncated protein for proPC2, and 
support in vitro experiments which show that recombinant 
21 kD 7B2 can bind to proPC2 immunoprecipitates (Braks 
and Martens, 1994).  Our data also show that expression of 
21 kD 7B2 is sufficient for the actual activation of PC2, as 
demonstrated by PC2 activity experiments using AtT-20/ 
PC2  and  CHO/PC2 cells in which  only cells which  have 
been  cotransfected  and  express 7B2  secrete  active PC2. 
Which enzyme actually performs the activation of proPC2, 
or whether proPC2 is autocatalytically activated, is as yet 
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Figure 9.  Secretion of PC2 activity is correlated with the expres- 
sion of 21 kD 7B2 in CHO/PC2 ceils. Overnight-conditioned  me- 
dium samples obtained from 11 independent clones of CHO/PC2 
cells stably transfected with 21 kD 7B2 cDNA were assayed for 
both 7B2 immunoreactivity and for PC2 activity. The correlation 
coefficient r  2 was 0.90. 
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secreted proPC2 with recombinant 21 kD rat 7B2 was not 
successful,  it  appears  that  7B2  must  be  present  intra- 
cellularly, either  during  synthesis of proPC2  or  shortly 
thereafter (however, it should be noted that postsynthesis 
activation was attempted only at neutral pH). These CHO/ 
PC2-7B2  cells  express  considerably more  proPC2  (ex- 
pressed  via the DHFR-coupled  amplification) than 7B2 
(expressed  through  simple  transfection  and  selection). 
However,  enzyme  activity produced  by  CHO/PC2-7B2 
cells has proven to be sufficient for the purification and 
characterization  of  active  recombinant  PC2,  and  such 
studies are now in progress (Lamango, N., and I. Lindberg, 
unpublished results). 
The carboxy-terminal peptide of 7B2 has been shown to 
be inhibitory to PC2 activity as well as to proPC2 activa- 
tion (Martens et al., 1994; Lindberg et al., 1995). The fact 
that both the 21-kD and the 27-kD 7B2 proteins exhibit a 
similar facilitatory function on proPC2 processing leads to 
the question of the normal role of the carboxy-terminal 
peptide in the processing of proPC2. When processing of 
7B2 to the 21-kD protein and the carboxy-terminal pep- 
tide was blocked by mutation of the normal pentabasic 
processing site, the mutated protein bound to proPC2, but 
did not facilitate proPC2  processing. Moreover, expres- 
sion of the blocked 7B2 protein prevented the cleavage of 
the PC2 proregion since in these cell lines proPC2 was se- 
creted intact into the medium (a process which was never 
otherwise observed). It appears that the removal or cleav- 
age of the carboxy terminal peptide is required for the 
autocatalytic cleavage of proPC2, most probably because 
the carboxy-terminal peptide occupies the  active site of 
proPC2  (thus  preventing  autoactivation).  We  observed 
that the binding of cleavage-site blocked 7B2 to proPC2 is 
tighter than that of 21 kD 7B2 (unpublished results), indi- 
cating that the presence of the inhibitory carboxy-terminal 
peptide (which has been shown to have a strong affinity 
for proPC2; Lindberg et al., 1995) increases the affinity of 
7B2 for proPC2. The mechanism for removal of the 7B2 
carboxy-terminal peptide is unclear at present. 
Based on the results discussed above, we propose  the 
following model for the interaction of PC2 with 7B2 in 
AtT20/PC2-7B2 cells (see Fig. 10): 
1)lnitial  binding of proPC2 and 27 kD  7B2 in the endoplasmic reticulum; 
transport to trans-Golgi network 
@  ÷  • 
27 kD  7B2  proPC2 ~  / 
2)  /~  proregion  ;  cleavage of 27 kD  7B2 by furin or PC1 
\  .... 
proPC2/rdeaved 71}2  complex 
/  slow cleavage of proPC2 (by autoactivation ?)  3) 
~,  ~  following dissociation of the carboxy terminal peptide 
~  1  ......  31 
active PC2  +  21 kD  7132 +  carboxy terminal peptide 
Figure 10.  Proposed mechanism of interaction of PC2 and 7B2. 
(1) Soon after synthesis, a portion of the available 27 kD 
7B2 and proPC2 bind each other in the endoplasmic retic- 
ulum; this binding results in the translocation of the com- 
plex to the TGN/secretory granules. The presence of the 
carboxyl-terminal inhibitory peptide of 27  kD  7B2 pre- 
vents the premature activation of proPC2 before arrival of 
the complex in the Golgi apparatus.The remainder of the 
27  kD  7B2  (i.e.,  the  portion  not  bound  to  proPC2)  is 
quickly transported through the secretory pathway, with a 
half-time of conversion of less than 15 min, and is secreted. 
(2)  In the TGN/immature secretory granule compart- 
ment(s), the 7B2 within the proPC2/27-kD 7B2 complex is 
rapidly cleaved to 21 kD 7B2 and the carboxy terminal in- 
hibitory peptide. The resulting complex, with the various 
molecules weakly associated, is now competent for cleav- 
age to the active form of PC2, possibly by autoactivation 
(Matthews et al., 1994; Shennan et al.,  1995). The rate of 
activation of each molecule of proPC2 may depend on the 
rate of dissociation/cleavage of its associated 7B2 carboxy- 
terminal inhibitory peptide. 
(3) Mature PC2 resulting from the above process is then 
free to cleave prohormone substrates/intermediates. 
No effects on POMC processing were observed in cell 
lines expressing either intact 27 kD 7B2, 21 kD 7B2, or the 
carboxy-terminal  domain  alone  (Mains,  R.  E.,  unpub- 
lished data). The lack of effect on peptide processing of 
the 21- and 27-kD 7B2 constructs, both of which increased 
the production of mature PC2, may be explained by pos- 
iting that POMC cleavage is already maximal in the parent 
cell line, and that it cannot be increased beyond this maxi- 
mum by the introduction of further active enzyme. This 
interpretation  is  supported  by  the  finding  of  almost 
complete cleavage of ACTH to a-MSH-sized peptides in 
AtT-20/PC2 cells (Zhou et al.,  1993).  The expression of 
endogenous 7B2 in these cells is apparently sufficient to 
support this high rate of cleavage. The lack of effect on 
POMC processing of cell lines overexpressing a carboxy- 
terminal inhibitory domain (residues 95-185) was expected 
since expression of this construct had no effect on the ki- 
netics of maturation of proPC2. 
In conclusion, it is likely that complex regulatory mecha- 
nisms limit the rate of peptide production, involving con- 
trol of the availability of active PC2 enzyme molecules in 
the correct subcellular compartment and regulation of PC2 
enzyme activity though the association/dissociation of inhib- 
itor molecules from activated and zymogen forms of PC2. 
Several  questions regarding the  interaction of PC2  and 
7B2  remain  to  be  answered,  for  example  the  site  and 
mechanism of dissociation of the inhibitory 7B2 carboxy- 
terminal peptide from proPC2. Future pulse-chase studies 
employing antisera to this portion of the 7B2 molecule will 
provide a better understanding of these cellular events and 
may one day provide a practical basis for the manipulation 
of peptide hormone levels. 
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Note Added in Proof. Benjannet et al. (1995) have recently reported intra- 
cellular binding of proPC2/PC2 to 7B2 forms (Benjannet, S., D. Savaria, 
M. Chretien, and N. G. Seidah. 1995. Z  Neurochem. 64:2303-2311).  7B2 is 
a specific intracellular binding protein of the prohormone convertase PC2. 
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